- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01857440
The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study (FLIPR)
Study Overview
Status
Conditions
Detailed Description
The pupils inside the eyes constrict in response to light stimulation. Different classes of cells within the human retina initiate this response. Recent research suggests that one of the ganglion cell types involved in this pupil response is affected by glaucoma. By measuring pupil responses to different colored lights, the function of this class of cells can be evaluated quickly, and without touching the eye. An advantage of pupil testing strategies is that they do not require subjective feedback from the subject about what they can see, as is required for standard visual field tests that are used in the clinic.
The main aim of this study is to measure and compare the pupil constriction that occurs in response to flickering red and blue lights in patients with glaucoma versus matched control patients without glaucoma. In addition, the subjects will be asked questions about their quality of life and it will be determined whether issues related to quality of life correlate to alterations in the pupil responses.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 42310
- OSU College of Optometry
-
Columbus, Ohio, United States, 43212
- Havener Eye Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18+ years old
- Diagnosed with glaucoma of known severity (cases only)
- Have a refractive error between +4.00 and -8.00 sphere power, and no more than 3.00 diopters of astigmatism
- Best corrected visual acuity of 20/40 or better in each eye
- Have open anterior chamber angles
Exclusion Criteria:
- Diagnosis of glaucoma of a type other than Primary Open Angle (cases only)
- History of having surgery or taking medications known to profoundly affect pupillary function or shape
- Visual Field defect (controls only)
- History of traumatic brain injury requiring hospitalization
- Pregnancy
- History of optic nerve disease other than glaucoma
- History of retinopathy
- History of unreactive pupils
- Presence of significant cataract
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
---|
Subjects with glaucoma (Cases)
This group will consist of patients with glaucoma who are under care at the Ohio State University Havener Eye Institute.
|
Subjects without glaucoma (Controls)
This group will consist of matched controls who are free of glaucoma and other complications, and who received a comprehensive eye examination at the Ohio State University College of Optometry.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pupil Response
Time Frame: Single Visit: One Day
|
Using fourier analysis, the pupil fluctuation evoked by blue and red flickering lights will be measured in glaucoma patients and compared to matched controls.
|
Single Visit: One Day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of Life Survey
Time Frame: Single Visit: One Day
|
Subjects will fill out a questionnaire with questions that assess quality of life issues, and the results will be correlated to the pupil response data.
|
Single Visit: One Day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Andrew Hartwick, OD, PhD, OSU College of Optometry
Publications and helpful links
General Publications
- Shorter P, Eren D, Jain SG, Hartwick ATE. 2014. The flashing light-induced pupil response (FLIPR) glaucoma study. Invest. Ophthalmol. & Vis. Sci. 55: E-abstract 5608.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013H0073
- 8KL2TR000112-05 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glaucoma, Open-Angle
-
AllerganRecruiting18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) (ARGOS)Ocular Hypertension | Open-angle GlaucomaUnited States
-
Aerie PharmaceuticalsCompletedOcular Hypertension | Open-angle Glaucoma
-
West Virginia UniversityUniversity of Pittsburgh; University of MichiganWithdrawnOpen-angle Glaucoma
-
Glaukos CorporationUnknownOpen-Angle GlaucomaSpain, Germany, Austria, Turkey
-
Alcon ResearchWithdrawnOpen-Angle Glaucoma
-
Asociación para Evitar la Ceguera en MéxicoUnknown
-
Pharmaceutical Research NetworkCompleted
-
National Eye Institute (NEI)CompletedOpen-Angle Glaucoma